Asia Pacific Joint Pain Injection Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Drugs (Hyaluronic Acid, Corticosteroid, and Others), Joint Type (Knee, Foot and Ankle, Shoulder and Elbow, Hip, and Others), and Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, and Others)

No. of Pages: 134    |    Report Code: TIPRE00024539    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Joint Pain Injection Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Joint Pain Injection Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Joint Pain Injection Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in joint-related disorders
  • 5.1.2 Rising demand for non-invasive treatments
5.2 Market Opportunities
  • 5.2.1 Expansion in orthopedic and pain management sectors
  • 5.2.2 Rise in non-invasive joint treatments
5.3 Future Trends
  • 5.3.1 Advances in minimally invasive joint pain therapies
  • 5.3.2 Rise in patient-specific treatments
5.4 Impact of Drivers and Restraints

6. Asia Pacific Joint Pain Injection Market Regional Analysis

6.1 Asia Pacific Joint Pain Injection Market Overview
6.2 Asia Pacific Joint Pain Injection Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Joint Pain Injection Market Forecast Analysis

7. Asia Pacific Joint Pain Injection Market Analysis – by Drugs

7.1 Hyaluronic Acid
  • 7.1.1 Overview
  • 7.1.2 Hyaluronic Acid: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Corticosteroid
  • 7.2.1 Overview
  • 7.2.2 Corticosteroid: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Joint Pain Injection Market Analysis – by Joint Type

8.1 Knee
  • 8.1.1 Overview
  • 8.1.2 Knee: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Foot and Ankle
  • 8.2.1 Overview
  • 8.2.2 Foot and Ankle: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Shoulder and Elbow
  • 8.3.1 Overview
  • 8.3.2 Shoulder and Elbow: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hip
  • 8.4.1 Overview
  • 8.4.2 Hip: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Joint Pain Injection Market Analysis – by Distribution Channel

9.1 Retail Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Hip: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Hospitals Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Hip: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Joint Pain Injection Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Joint Pain Injection Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 Asia Pacific Joint Pain Injection Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Joint Pain Injection Market Breakdown, by Drugs
    • 10.1.1.1.2 China: Asia Pacific Joint Pain Injection Market Breakdown, by Joint Type
    • 10.1.1.1.3 China: Asia Pacific Joint Pain Injection Market Breakdown, by Distribution Channel
  • 10.1.1.2 India: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Joint Pain Injection Market Breakdown, by Drugs
    • 10.1.1.2.2 India: Asia Pacific Joint Pain Injection Market Breakdown, by Joint Type
    • 10.1.1.2.3 India: Asia Pacific Joint Pain Injection Market Breakdown, by Distribution Channel
  • 10.1.1.3 Japan: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Joint Pain Injection Market Breakdown, by Drugs
    • 10.1.1.3.2 Japan: Asia Pacific Joint Pain Injection Market Breakdown, by Joint Type
    • 10.1.1.3.3 Japan: Asia Pacific Joint Pain Injection Market Breakdown, by Distribution Channel
  • 10.1.1.4 Australia: Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Joint Pain Injection Market Breakdown, by Drugs
    • 10.1.1.4.2 Australia: Asia Pacific Joint Pain Injection Market Breakdown, by Joint Type
    • 10.1.1.4.3 Australia: Asia Pacific Joint Pain Injection Market Breakdown, by Distribution Channel
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Joint Pain Injection Market Breakdown, by Drugs
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Joint Pain Injection Market Breakdown, by Joint Type
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Joint Pain Injection Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Joint Pain Injection Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Chugai Pharmaceutical Co., Ltd.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bioventus Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Fidia Pharma USA Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Seikagaku Corporation
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Ferring B.V.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Sanofi
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Anika Therapeutics, Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Teva Pharmaceutical Industries Ltd.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Asia Pacific Joint Pain Injection Market

  1. Chugai Pharmaceutical Co., Ltd.
  2. Bioventus Inc.
  3. Fidia Pharma USA Inc.
  4. Seikagaku Corporation
  5. Ferring B.V.
  6. Sanofi
  7. Anika Therapeutics, Inc.
  8. Teva Pharmaceutical Industries Ltd.
asia-pacific-joint-pain-injection-market